Dr. Emily Gallagher, MD

• Endocrinology, Diabetes & Metabolism

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: beyond autoimmune insulin-dependent diabetes, 2020-12-23

• Obesity, Type 2 Diabetes, and Cancer Risk, 2021-02-02

• Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: Hypothesis and Proposed Pathways, 2016-04-21

• Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer, 2019-07-17

• Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model, 2018-04-14

• Statin Use and Breast Cancer Prognosis in Black and White Women, 2017-10-19

• Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes, 2016-05-30

• Silencing Vimentin Expression Decreases Pulmonary Metastases in a Pre-Diabetic Mouse Model of Mammary Tumor Progression, 2016-08-29

• Non-Obese MKR Mouse Model of Type 2 Diabetes Reveals Skeletal Alterations in Mineralization and Material Properties Tice et al., 2021-12-16

• Structural insights into the career path between pre- and postgraduate physician-scientist training programs, 2023-10-02

• The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice, 2015-03-08

• OP449 Inhibits Human Breast Cancer Growth without Adverse Metabolic Effects, 2017-07-28

• Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results -Medicare analysis of 5235 patients, 2021-04-09

• EMT Reversal in human cancer cells after IR knockdown in hyperinsulinemic mice, 2016-07-19

• The Proliferating Role of Insulin and Insulin-Like Growth Factors in Cancer, 2010-07-19

• Risk factors for emergency room and hospital care among patients with solid tumors on immune checkpoint inhibitor therapy., 2021-03-01

• Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis, 2022-08-12

• Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice, 2015-09-17

• The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes, 2017-04-21

• Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer, 2015-06-15

• Pearls of wisdom for aspiring physician-scientist residency applicants and program directors, 2022-03-22

• Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling, 2021-09-09

• Obesity and Cancer, 2022-07-20

• Breast tumor IGF1R regulates cell adhesion and metastasis: alignment of mouse single cell and human breast cancer transcriptomics, 2022-12-07

• TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer, 2021-12-06

• IGF-1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors, 2014-08-04

• Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis, 2019-09-12

• Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design, 2023-06-23

• Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms, 2019-11-12

• Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor, 2023-06-29

• Insulin resistance contributes to racial disparities in breast cancer prognosis in US women, 2020-05-12

• Metabolic disease and adverse events from immune checkpoint inhibitors, 2021-05-10

• Survival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus, 2021-10-01